Additionally, inhibiting far upstream element binding protein 1 (FBP1) has been shown to increase hepatocellular carcinoma (HCC) sensitivity towards apoptotic stimulation, which therefore inhibits cell proliferation (42). This evidence concerns the gene FBP1 and hepatocellular carcinoma.